Over the past few decades, prostate cancer has become better understood and treated more effectively.
So much has changed since Terry Fischer was diagnosed with prostate cancer in 1994.
Fischer said that he is enthusiastic about the increase of knowledge and understanding around the disease, more efficacious treatments, as well as treatment sequencing. All of that was not available when he was diagnosed more than two decades ago.
Novel Drug Granted FDA Fast Track in Rare Prostate Cancer Subset
February 13th 2024The Food and Drug Administration has granted a Fast Track designation to the novel immune activator drug BXCL701 in combination with a checkpoint inhibitor for patients with metastatic small cell neuroendocrine prostate cancer (SCNC).
Read More